Repositioning Candidate Details
| Candidate ID: | R0418 |
| Source ID: | DB03852 |
| Source Type: | experimental; nutraceutical |
| Compound Type: | small molecule |
| Compound Name: | Eucalyptol |
| Synonyms: | |
| Molecular Formula: | C10H18O |
| SMILES: | C[C@@]12CC[C@@H](CC1)C(C)(C)O2 |
| Structure: |
|
| DrugBank Description: | Eucalyptol is naturally produced cyclic ether and monoterpenoid. Eucalyptol is an ingredient in many brands of mouthwash and cough suppressant. It controls airway mucus hypersecretion and asthma via anti-inflammatory cytokine inhibition. Eucalyptol is an effective treatment for nonpurulent rhinosinusitis. Eucalyptol reduces inflammation and pain when applied topically. It kills leukaemia cells in vitro. |
| CAS Number: | 470-82-6 |
| Molecular Weight: | 154.2493 |
| DrugBank Indication: | |
| DrugBank Pharmacology: | |
| DrugBank MoA: | |
| Targets: | |
| Inclusion Criteria: |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|